Hosted on MSN1mon
Why Trevena (TRVN) Stock Is Down 43% TodayTrevena Inc (NASDAQ:TRVN) shares are trading lower by 43.3% to $2.61 during Monday’s session after the company announced it received a Nasdaq delisting notification. What Else: Trevena late ...
Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq ... long-term analgesic effect in preclinical model of neuropathic pain, with no evidence of receptor desensitization TRV045 demonstrates ...
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) has announced a significant amendment to its existing royalty-based financing agreement with R-Bridge Healthcare Fund, L.P. This amendment brings ...
CHESTERBROOK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ...
CHESTERBROOK, Pa. (AP) — CHESTERBROOK, Pa. (AP) — Trevena Inc. (TRVN) on Thursday reported a loss of $4.9 million in its third quarter. The Chesterbrook, Pennsylvania-based company said it had ...
Trevena shares are trading lower by 47% during Monday's session. The company announced it received a Nasdaq delisting notification.
CHESTERBROOK, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ...
CHESTERBROOK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback